Blog

Biosample Permission Token with Non-Fungible Tokens

A new model for tracking permissions using established blockchain standards, and an application for biosample data, is introduced.

Read More

Block.one Invests $50,000 Into Blockchain-Based COVID-19 Testing App

Block.one, the company behind EOSIO (EOS), issued a $50,000 grant to Genobank for its open-source app on April 29

Read More

COVID-19 Vaccine Authenticity Token Using a Public Blockchain

How we can deliver safe and authentic vaccines, and allow patients to lead normal lives when they are immune to COVID-19. Secure immunization information systems.

Read More

Daniel Uribe CEO Genobank.io (Republic)

CEO Daniel Uribe message for investors Republic.co/genobank-io Crowdfunding Campaign 2020

Read More

Daniel Uribe | GenoBank.io: blockchain & genética de la salud

Daniel es un emprendedor serial, especialista en ciberseguridad e inversor ángel en blockchain. Es exalumno de Stanford y Singularity University.

Read More

Daniel Uribe, Genobank.io Finding Faith in Science, and Humanity

My motivation for founding Genobank is much more than creating a sustainable business. Genobank is mission driven, with our aim being to provide humanity with access to and control over their DNA.

Read More

Block.one Invests $50K For Developing COVID-19 Testing App

The company behind EOSIO, Block.one invests $50,000 grant as the Genobank announced at the start of this month saying that the app, Agerona

Read More

Decentralized Biospecimen governance using Blockchain

Welcome to the future of biospecimen decentralized ownership and governance using non-fungible-tokens (NFTs) based on #ERC721. Blockchain is now being used to personalize biospecimen collection and distribution allowing donors to determine how their specimens will be used in research.

Read More

Did your health records get hacked yet?

5 reasons how GenoBank.io helps prevent with future hacks"

Read More

EOS Nation Infrastructure Improvements, EOS VC Grants, EOSIO Challenge Winner, EOS Lost Keys & More!

Our mission is to secure EOSIO blockchains with reliable infrastructure and to build a global community empowered with the tools and resources to thrive. We’re committed to leading and contributing to projects that add value to the ecosystem.

Read More

GDPR compliant secure encrypted sharing of genomic data using Blockchain technology

A new model for tracking permissions using established blockchain standards, and an application for biosample data, is introduced.

Read More

Genobank Closes In On Half a Million Dollars in Equity Crowdfunding at Republic

Genobank.io — who claim they are the first-ever anonymous, privacy-preserving DNA extraction kit — has reached $418,000 in crowdfunding from over 1,400 investors around the world

Read More

Genobank.io (Beta) Technology Preview

Please join our beta technology preview on how Genobank.io enables users establish ownership and control over their Biosamples using a traceable Non-fungible-token (NFT) or a 'Biosample Consent Token'.

Read More

Meet the Drapers | Vivoo, Hearo.Live, and Genobank.io with Naveen Jain & Grant Cardone

Tim, Bill, and Polly Draper are back to find investment-worthy companies. Special guest include judges: Naveen Jain, founder and CEO of Viome and Grant Cardone.

Read More

GenoBank.io & Laboratory/Biobank Memorandum of Understanding

This document is a sample agreement that GenoBank.io and a laboratory/biobank would execute so as to enable processing of an pseudonymous donor’s biometric information/biosamples

Read More

Update: Genobank.io Raises Nearly $435,000 Through Republic Funding Round

Incognito and encrypted DNA extraction kit brand, Genobank.io, has successfully raised nearly $435,000 in funding through its crowdfunding round on Republic.

Read More

What happens when your DNA and Genetic Data goes on the Blockchain?

The battle of legitimate authority and control over genomicsdata introduces a substantial legal andcomputational burden on data privacy.

Read More

News & Updates

Get access to the latest insights, tips and trends in genetic research study